- Filed
- May 14, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · May 4, 2021 | 2.97M sh |
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $27.03M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $32.35M |
| Cash And Equivalents | Q1 2021 · Mar 31, 2020 | $15.66M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2019 | $37.74M |
| Total Liabilities | Q1 2021 · Mar 31, 2021 | $197.91M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $195.63M |
| Total Assets | Q1 2021 · Mar 31, 2021 | $240.71M |
| Total Assets | Q1 2021 · Dec 31, 2020 | $237.13M |
| Cost Of Revenue | Q1 2021 · Mar 31, 2021 | $26.76K |
| Cost Of Revenue | Q1 2021 · Mar 31, 2020 | $32.97K |
| Shares Diluted restated | Q1 2021 · Mar 31, 2020 | 2.76M sh |
| Capex | Q1 2021 · Mar 31, 2020 | $207.29K |
| Operating Cash Flow | Q1 2021 · Mar 31, 2020 | −$5.87M |
| Stockholders Equity | Q1 2021 · Mar 31, 2020 | $37.91M |
| Stockholders Equity | Q1 2021 · Dec 31, 2019 | $23.84M |
| Eps Diluted | Q1 2021 · Mar 31, 2020 | −$0.08 |
| Eps Basic | Q1 2021 · Mar 31, 2020 | −$0.08 |
| Net Income | Q1 2021 · Mar 31, 2020 | −$226.05K |